Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. de Margerie-Mellon reports grants from Institut Servier, grants from Olea Medical, outside the submitted work.
Conflict of interest: Dr. Belin has nothing to disclose.
Conflict of interest: Dr. Boussouar has nothing to disclose.
Conflict of interest: Dr. Khafagy has nothing to disclose.
Conflict of interest: Dr. Debray reports personal fees and non-financial support from Boehringer-Ingelheim, personal fees and non-financial support from Roche, outside the submitted work.
Conflict of interest: Dr. Levand has nothing to disclose.
Conflict of interest: Dr. Chabi has nothing to disclose.
Conflict of interest: Dr. KHALIL has nothing to disclose.
Conflict of interest: Dr. Benattia has nothing to disclose.
Conflict of interest: Dr. Israël-Biet has nothing to disclose.
Conflict of interest: Dr. crestani reports personal fees and non-financial support from astra zeneca, grants, personal fees and non-financial support from boehringer ingelheim, grants from MedImmune, grants, personal fees and non-financial support from Roche, personal fees from Sanofi, outside the submitted work.
Conflict of interest: Dr. Nunes reports grants and personal fees from Roche/Genentech, grants and personal fees from Boehringer Ingelheim, outside the submitted work.
Conflict of interest: Dr. Cadranel has nothing to disclose.
Conflict of interest: Dr. GRENIER has nothing to disclose.
Conflict of interest: Dr. Valeyre reports personal fees from Boehringer ingelheim, personal fees from Roche, personal fees from Boehringer ingelheim Roche, outside the submitted work.
Conflict of interest: Dr. Naccache has nothing to disclose.
Conflict of interest: PYB has received personal fees for teaching actions from Boehringer Ingelheim and Roche.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received January 2, 2019.
- Accepted October 4, 2019.
- Copyright ©ERS 2019